Topical formulations comprising a combination with montelukast and mussel adhesion proteins

摘要

Topical pharmaceutical formulations comprising pharmaceutically acceptable salts of montelukast, or solvates thereof, as well as (a) at least one mussel adhesion protein or derivative thereof; And (b) montelukast, or a pharmaceutically-acceptable salt or solvate thereof. The formulation and combination products are particularly useful for direct topical administration for the treatment of conditions characterized by inflammation, inflammatory disorders and / or inflammation, including wounds, burns, psoriasis, acne and atopic dermatitis.